Latest news
11-10-2023 - Pre-Announcement of MRC Cancer Immunotherapy Response Research Platform Opportunity
Funding to develop a consortium based, broad utility, deep genotyping and phenotyping platform capable of generating breakthrough insights into patient response, adverse effects, and resistance to immunotherapy.
The Medical Research Council (MRC) has launched a pre-announcement of a future opportunity to develop a consortium based, broad utility, deep genotyping and phenotyping platform of equipment, staff and expertise, capable of generating breakthrough insights into patient response, adverse effects, and resistance to immunotherapy, and exemplar project(s) to demonstrate utility.
[...]